Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction | MicrobiomeTrials← Back to trialsNCT04650568
Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2017-11-03Est. Completion: 2027-05-03
Enrollment target: 100 participants Locations- Rush University Medical Center, Chicago, Illinois, United States
Other microbiome trials you might be interested in
Anterior Cruciate Ligament ReconstructionTotal Hip Arthroplasty (THA)Total Knee ArthroplastyHip Arthroscopy
After orthopedic surgeries like knee or hip replacement, some patients struggle to fully activate their muscles due to a…
Chicago, United StatesEst. completion May 1, 2028
Knee InjuryACL InjuryMeniscus TearHispanic or LatinoAdolescent
Hundreds of thousands of youth athletes require surgery for knee injuries annually. The incidence of operative knee inju…
Chicago, United StatesEst. completion Jun 2029